Profile data is unavailable for this security.
About the company
Medical Developments International Limited is an Australia-based company that delivers emergency medical solutions dedicated to improving patient outcomes in both domestic and international markets. The Company operates in two segments: Pain Management and Respiratory. The Pain Management segment is engaged in the supply of analgesia for acute and procedural pain. The Company manufactures an inhaled analgesic, Penthrox (the Green Whistle), at manufacturing facilities at Scoresby and Springvale in Victoria, Australia. Penthrox is sold into domestic and international markets through distribution partnerships and direct in-market capability. The Respiratory segment is a supplier of respiratory products including asthma and chronic obstructive pulmonary disease (COPD) space chambers, peak flow meters, portable nebulizers and silicone face masks. The respiratory supplies into Australia, the United States of America, Europe, and Asia through partnerships with distributors.
- Revenue in AUD (TTM)40.64m
- Net income in AUD-436.00k
- Incorporated2003
- Employees68.00
- LocationMedical Developments International Ltd4 Caribbean Drive, ScoresbyMELBOURNE 3179AustraliaAUS
- Phone+61 39547-1888
- Fax+61 39547-0262
- Websitehttps://www.medicaldev.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Epsilon Healthcare Ltd | 6.13m | -6.12m | 10.51m | -- | -- | -- | -- | 1.71 | -0.0164 | -0.0164 | 0.0167 | -0.0097 | 0.462 | -- | 4.95 | -- | -46.14 | -33.37 | -156.14 | -46.46 | 52.23 | 49.34 | -99.85 | -136.16 | 0.3775 | -3.92 | 1.67 | -- | -15.81 | 3.16 | -403.56 | -- | -32.83 | -- |
| Calmer Co International Ltd | 8.03m | -3.99m | 10.70m | -- | -- | 5.54 | -- | 1.33 | -0.0015 | -0.0015 | 0.0029 | 0.0006 | 1.60 | 3.29 | 14.33 | -- | -79.73 | -109.82 | -171.17 | -197.50 | 42.49 | 41.18 | -49.69 | -128.71 | 1.22 | -11.32 | 0.5482 | -- | 88.48 | 59.99 | -7.13 | -- | 27.67 | -- |
| Firebrick Pharma Ltd | 159.94k | -2.45m | 13.89m | -- | -- | 7.14 | -- | 86.82 | -0.0106 | -0.0106 | 0.0007 | 0.0077 | 0.0777 | 0.4045 | 1.30 | -- | -119.12 | -98.41 | -142.70 | -109.28 | -9.34 | -- | -1,532.61 | -5,384.55 | 4.60 | -- | 0.00 | -- | 1,920.80 | -- | -124.04 | -- | -- | -- |
| Oncosil Medical Ltd | 1.59m | -12.92m | 15.47m | 2.00 | -- | 3.23 | -- | 9.70 | -0.9425 | -0.9425 | 0.104 | 0.2028 | 0.1711 | -- | 3.47 | -- | -138.67 | -97.54 | -207.63 | -117.83 | -66.32 | -54.05 | -810.45 | -1,258.41 | -- | -386.47 | 0.011 | -- | 116.34 | -15.15 | -26.74 | -- | -6.31 | -- |
| Vitura Health Ltd | 124.04m | 3.28m | 27.84m | 119.00 | 7.78 | 0.577 | 5.25 | 0.2244 | 0.0054 | 0.0054 | 0.2034 | 0.0728 | 1.69 | 16.43 | 10.46 | -- | 4.11 | 12.75 | 5.72 | 17.62 | 27.21 | 30.97 | 2.43 | 6.06 | 1.05 | 9.50 | 0.2009 | -- | 0.1341 | 298.23 | -5.35 | -- | 129.38 | -- |
| TrivarX Ltd | 1.13m | -943.23k | 28.84m | 4.00 | -- | 1.22 | -- | 25.46 | -0.0018 | -0.0018 | 0.0023 | 0.0204 | 0.0923 | -- | -- | -- | -7.68 | -33.47 | -8.32 | -37.46 | -- | -- | -83.27 | -373.85 | -- | -27.05 | 0.0132 | -- | 26.38 | 3.89 | 34.25 | -- | 6.29 | -- |
| Little Green Pharma Ltd | 38.49m | 5.86m | 33.64m | -- | 5.68 | 0.3909 | 3.47 | 0.874 | 0.0194 | 0.0194 | 0.1268 | 0.2814 | 0.4262 | 0.8199 | 14.01 | -- | 6.48 | -- | 7.09 | -- | 67.46 | -- | 15.21 | -- | 0.8728 | -4.71 | 0.0541 | -- | 43.67 | -- | 140.77 | -- | -- | -- |
| Avecho Biotechnology Ltd | 1.38m | -3.62m | 36.73m | 29.00 | -- | 38.46 | -- | 26.61 | -0.0011 | -0.0011 | 0.0004 | 0.0003 | 0.2115 | 4.46 | 1.91 | -- | -55.49 | -61.23 | -72.92 | -73.27 | 62.27 | 55.45 | -262.41 | -382.04 | 4.53 | -8.03 | 0.0647 | -- | 139.19 | -23.20 | 9.15 | -- | -- | -- |
| Inoviq Ltd | 916.53k | -7.24m | 46.46m | 85.00 | -- | 2.09 | -- | 50.69 | -0.0615 | -0.0615 | 0.0078 | 0.1581 | 0.0401 | 3.61 | 0.9209 | -- | -31.68 | -43.01 | -34.39 | -45.87 | 86.76 | 89.08 | -789.61 | -1,543.44 | 7.54 | -- | 0.012 | -- | 21.17 | 57.69 | -5.77 | -- | -- | -- |
| Medical Developments International Ltd | 40.64m | -436.00k | 49.57m | 68.00 | -- | 0.9051 | 19.55 | 1.22 | -0.0039 | -0.0039 | 0.3608 | 0.4862 | 0.6306 | 1.30 | 5.32 | -- | -0.6765 | -16.68 | -0.7455 | -18.92 | 75.19 | 72.70 | -1.07 | -47.08 | 4.54 | -- | 0.0324 | -- | 17.82 | 11.30 | 100.23 | -24.33 | -34.91 | -- |
| Neurizon Therapeutics Ltd | 126.01k | -14.85m | 62.88m | 52.00 | -- | 5.82 | -- | 498.98 | -0.0293 | -0.0293 | 0.0003 | 0.0155 | 0.0082 | -- | 3.87 | -- | -96.23 | -65.69 | -146.99 | -74.86 | -- | -- | -11,785.73 | -368.00 | -- | -201.18 | 0.1636 | -- | -- | -- | -86.45 | -- | -44.79 | -- |
| Holder | Shares | % Held |
|---|---|---|
| Regal Funds Management Pty Ltd.as of 15 Aug 2025 | 10.62m | 9.43% |
| Netwealth Investments Ltd.as of 15 Aug 2025 | 3.95m | 3.50% |
| FIL Investment Management (Hong Kong) Ltd.as of 31 Dec 2025 | 2.91m | 2.59% |
| FIL Pensions Managementas of 30 Jun 2025 | 931.64k | 0.83% |
| DFA Australia Ltd.as of 31 Jan 2026 | 680.85k | 0.60% |
